Structured evidence table for Creatine Sleep Latency Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Creatine Sleep Latency Randomized Trial | 14 15 Evidence on specific supplements suggests potential but limited benefit to dancers. | 1 | Vela-Andreu Marian (2026) | Dietary supplement and medication use in professional and pre-professional dancers: widespread use but limited evidence of benefit—a systematic review |
| Creatine Sleep Latency Randomized Trial | Vitamin D insufficiency has been associated with increased risk of musculoskeletal injury, and interventional studies in a small population of dancers suggest potential reductions in injury incidence and enhanced muscle function with supplementation, although dancer-specific evidence remains scarce (). | 1 | Vela-Andreu Marian (2026) | Dietary supplement and medication use in professional and pre-professional dancers: widespread use but limited evidence of benefit—a systematic review |
| Creatine Sleep Latency Randomized Trial | Contemporary meta-analyses and systematic reviews in athletes found that NSAIDs do not reliably improve neuromuscular performance or recovery and their routine prophylactic use is not supported as an ergogenic strategy (), even though recent evidence highlights the potential hypertrophy benefits (). | 1 | Vela-Andreu Marian (2026) | Dietary supplement and medication use in professional and pre-professional dancers: widespread use but limited evidence of benefit—a systematic review |
| Creatine Sleep Latency Randomized Trial | 1 2 2 3 4 Professional and pre-professional dancers represent a population with exceptional physical demands, combining high volumes of repetitive loading, extreme ranges of motion, coordination, and balance (,). | 1 | Vela-Andreu Marian (2026) | Dietary supplement and medication use in professional and pre-professional dancers: widespread use but limited evidence of benefit—a systematic review |
| Creatine Sleep Latency Randomized Trial | 1 2 3 4 Insufficient sleep constitutes a risk factor for adverse cardiometabolic effects, such as weight gain and obesity []. | 4 | Good Linnéa (2026) | Body-weight-specific and shared metabolomic responses to acute sleep loss in young adults |
| Creatine Sleep Latency Randomized Trial | Conversely, obesity is also associated with disrupted sleep and worse sleep quality [,]. | 4 | Good Linnéa (2026) | Body-weight-specific and shared metabolomic responses to acute sleep loss in young adults |
| Creatine Sleep Latency Randomized Trial | Epidemiological studies indicate that variation in sleep duration may result in differential effects on cardiometabolic outcomes in individuals with versus without obesity []. | 4 | Good Linnéa (2026) | Body-weight-specific and shared metabolomic responses to acute sleep loss in young adults |
Source documents